Orchestra BioMed Holdings, Inc. operates as a biomedical company in the United States. The company's flagship product candidates include Atrioventricular Interval Modulation, a bioelectronic therapy candidate designed to immediately, substantially, and persistently lower blood pressure; and Virtue...
32 insider purchases on record · latest filing 2026-09-08.
Insiders have also filed 15 sale transactions at OBIO.